Editorial Board / Contents / Imprint
Sylvia Timme, Druck Ausrüstung Kraft-Druck GmbH, Pascal Baltzer(Medical University of Vienna), Carla Meeuwis, Simon Cawthorn(North Bristol NHS Trust), Katja Pinker(Medical University of Vienna), Paola Clauser, Elmar Stickeler(Universitätsklinikum Aachen), Dominique J P van Uden, Dieter Hauschke(University Medical Center Freiburg), Flaminia Marzocca, Evelyn Wenkel(BMW (Germany)), Clemens G. Kaiser(University Medical Centre Mannheim), Chiara Zuiani(University of Udine), Francesca Galati(Sapienza University of Rome), Raghavan Vidya, Massimo Bazzocchi(University of Udine), Sharon Tan, Federica Pediconi, Magda Marcon(Spital Lachen), Viviana Londero, Barbara Bennani Baiti(Medical University of Vienna), Marcus Schmidt(Johannes Gutenberg University Mainz), Rüdiger Schulz‐Wendtland(Leiden University), E. Bassetti, Mohammad Elkady, C.F.J.M. Blanken-Peeters(Rijnstate Hospital), Carlo Catalano(Unknown), Ritse M. Mann(Radboud University Nijmegen), Peter Bronsert(University of Freiburg), Matthias Dietzel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Martin Sillem, Maria Laura Luciani, Michael Uder(SUNY Upstate Medical University), Tanja Fehm(Düsseldorf University Hospital), Martin Werner(University Medical Center Freiburg), Mohammed A. Osman, Volkmar Müller(Universität Hamburg), Johannes H. W. de Wilt(Radboud University Nijmegen), Lioudmila Bogatyreva, Matthias Hammon(Friedrich-Alexander-Universität Erlangen-Nürnberg), Cornelia Liedtke, Axel zur Hausen(Maastricht University Medical Centre)
Cited by 1
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Breast MRI: guidelines from the European Society of Breast Imaging
|European Radiology|2008|819
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists
|JNCI Journal of the National Cancer Institute|2018|674